冠科生物,Crown Bioscience ,
中美冠科生物技术有限公司成立于2006年，是一家出色的新药研发公司。在其专注的肿瘤和代谢疾病领域，冠科为生物科技和药业合作伙伴提供最先进的转化医学研究平台和高效的新药研发解决方案。冠科独有的HuPrime®, HuKemia®, HuBase®，HuTrialTM, HuSignatureTM 和HuMark™技术平台提供特有的先导化合物优化和转化医学研究策略，获得更优秀的临床候选化合物。总部设在美国加利福利亚州圣塔克拉拉市（Santa Clara，California），在美国北卡罗来纳州、英国中部、中国北京市和江苏省太仓市均设有含动物房的生物医药研发中心。并在美国波士顿、普林斯顿、RTP、菲尼克斯、英国诺丁汉和意大利米兰及中国上海设有办事处

Founded in 2006, Crown Bioscience is a premier drug discovery company providing cutting-edge translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our proprietary HuPrime®, HuKemia®, HuBase™, HuTrial™, HuSignature™, HuBank ™, HuTissue™, and HuMark™ platforms enable unique lead optimization and translational strategies to deliver superior drug candidates. Headquartered in Santa Clara California, Crown Bioscience has global operations in China (Beijing and Jiangsu Taicang), the USA (NC), UK (Nottingham), and also with business offices in the Santa Clara, Boston, Princeton, RTP, Indianapolis, Phoenix, Milan and Shanghai.